Domov › Rak pljuč › New York › New York City
Klinične študije za Rak pljuč v New York City, NY
60 študij za Rak pljuč išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of ZW251 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Mental Health Care in People With Cancer
Vključevanje udeležencev
- Memorial Sloan Kettering Cancer Center, New York
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering (Melanoma/NSCLC), New York
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Vključevanje udeležencevFaza 3
- Mount Sinai Chelsea, New York
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Empathic Communication Skills (ECS) Training
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Hospital, New York
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Vključevanje udeležencevFaza 3
- NYU Langone's Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Vključevanje udeležencevFaza 3
- Memorial Sloan Kettering Cancer Center, New York
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center, New York
A Registry for People With Lung Cancer
Vključevanje udeležencevOpazovalna študija
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Vključevanje udeležencevFaza 2/3
- NYU Langone Health, New York
- Weill Cornell Medical College, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Vključevanje udeležencevFaza 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Vključevanje udeležencevFaza 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Laura and Isaac Perlmutter Cancer Center, New York
- Manhattan Eye, Ear and Throat Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, New York
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 1
- Perlmutter Cancer Center - NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Vključevanje udeležencevFaza 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Vključevanje udeležencevFaza 3
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Vključevanje udeležencevFaza 1
- New York Cancer & Blood Specialists, New York
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- New York Proton Center, New York
- Manhattan Eye Ear and Throat Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
- in še 1
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- New York Proton Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Lung Cancer Risk
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Vključevanje udeležencevFaza 1
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Vključevanje udeležencev
- City College of New York (Data Collection AND Specimen Analysis), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- New York University Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Vključevanje udeležencevFaza 2
- New York University Langone Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- NYU Langone Medical Center, New York
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Vključevanje udeležencevFaza 1/2
- Weill Medical College of Cornell University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Vključevanje udeležencevFaza 1
- Research Site, New York
- Research Site, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Vključevanje udeležencevFaza 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Vključevanje udeležencevFaza 1
- Columbia University Irving Medical Center, New York
Lung Cancer Biomarkers and Screening
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- NYU Cancer Institute at New York University Medical Center, New York
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Vključevanje udeležencevFaza 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Vključevanje udeležencevFaza 2
- Weill Cornell Medicine, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Vključevanje udeležencevFaza 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Confocal Laser Endomicroscopy VERification
Vključevanje udeležencev
- Montefiore Medical Center, New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Vključevanje udeležencevOpazovalna študija
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Vključevanje udeležencevFaza 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer
Vključevanje udeležencevOpazovalna študija
- NYU Langone Health, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- NYU Langone Health, New York
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
Vključevanje udeležencevFaza 2
- NYU Langone Health, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Vključevanje udeležencevOpazovalna študija
- Icahn School of Medicine at Mount Sinai, New York
Comprehensive Outcomes for After Cancer Health
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Memorial Sloan Kettering Cancer Center, New York
Študije za Rak pljuč v drugih mestih
- Houston, TX78 študij
- Boston, MA62 študij
- Los Angeles, CA45 študij
- Arlington, VA41 študij
- Washington, DC41 študij
- Chicago, IL41 študij
- Baltimore, MD40 študij
- Nashville, TN40 študij
- St. Louis, MO39 študij
- Columbus, OH37 študij
- Philadelphia, PA36 študij
- Seattle, WA33 študij
Druge študije v New York City
- Rak dojke136 študij
- Nemalicelični pljučni rak121 študij
- Rak (vse vrste)109 študij
- Rak prostate103 študij
- Metastatski rak93 študij
- Kolorektalni rak78 študij
- Rak jajčnikov69 študij
- Množni mielom60 študij
- Rak trebušne slinavke60 študij
- Rak endometrija52 študij
- Akutna mieločna levkemija51 študij
- Srčno popuščanje51 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.